(19)

(11)

EP 4 460 299 A2

(12)

(88) Date of publication A3: 28.09.2023 (43) Date of publication: 13.11.2024 Bulletin 2024/46 (21) Application number: 22919247.1 (22) Date of filing: 22.12.2022

(51) International Patent Classification (IPC):  A61K 31/404(2006.01) A61P 35/00(2006.01) A61K 9/00(2006.01) G01N 33/574(2006.01) (52) Cooperative Patent Classification (CPC): A61K 31/437; A61K 31/33; A61K 31/496; A61K 31/517   C-Sets: A61K 31/437, A61K 2300/00; A61K 31/33, A61K 2300/00; A61K 31/496, A61K 2300/00; A61K 31/517, A61K 2300/00; (86) International application number: PCT/US2022/082270 (87) International publication number: WO 2023/133053 (13.07.2023 Gazette 2023/28)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 07.01.2022 US 202263297651 P (71) Applicant: Kojin Therapeutics, Inc. Boston, Massachusetts 02210 (US)	(72) Inventors: VISWANATHAN, Vasanthi Boston, Massachusetts 02210 (US) EATON, JR., John Kittridge Boston, Massachusetts 02210 (US) (74) Representative: Heller, Benjamin Henry et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)